195 related articles for article (PubMed ID: 20960188)
1. Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
Su Y; Jackson EK; Gorelik E
Cancer Immunol Immunother; 2011 Jan; 60(1):111-22. PubMed ID: 20960188
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
Raskovalova T; Lokshin A; Huang X; Su Y; Mandic M; Zarour HM; Jackson EK; Gorelik E
Cancer Res; 2007 Jun; 67(12):5949-56. PubMed ID: 17575165
[TBL] [Abstract][Full Text] [Related]
3. Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
Nguyen LT; Yen PH; Nie J; Liadis N; Ghazarian D; Al-Habeeb A; Easson A; Leong W; Lipa J; McCready D; Reedijk M; Hogg D; Joshua AM; Quirt I; Messner H; Shaw P; Crump M; Sharon E; Ohashi PS
PLoS One; 2010 Nov; 5(11):e13940. PubMed ID: 21085676
[TBL] [Abstract][Full Text] [Related]
4. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
[TBL] [Abstract][Full Text] [Related]
5. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
[TBL] [Abstract][Full Text] [Related]
6. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
[TBL] [Abstract][Full Text] [Related]
7. Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy.
Lee N; Zakka LR; Mihm MC; Schatton T
Pathology; 2016 Feb; 48(2):177-87. PubMed ID: 27020390
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy.
Mazzarella T; Cambiaghi V; Rizzo N; Pilla L; Parolini D; Orsenigo E; Colucci A; Modorati G; Doglioni C; Parmiani G; Maccalli C
Cancer Immunol Immunother; 2012 Aug; 61(8):1169-82. PubMed ID: 22207316
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G
J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469
[TBL] [Abstract][Full Text] [Related]
10. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Oble DA; Loewe R; Yu P; Mihm MC
Cancer Immun; 2009 Apr; 9():3. PubMed ID: 19338264
[TBL] [Abstract][Full Text] [Related]
11. Large-scale bioreactor expansion of tumor-infiltrating lymphocytes.
Sadeghi A; Pauler L; Annerén C; Friberg A; Brandhorst D; Korsgren O; Tötterman TH
J Immunol Methods; 2011 Feb; 364(1-2):94-100. PubMed ID: 21111743
[TBL] [Abstract][Full Text] [Related]
12. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
González FE; Ramírez M; Allerbring EB; Fasching N; Lundqvist A; Poschke I; Achour A; Salazar-Onfray F
Immunobiology; 2014 Mar; 219(3):189-97. PubMed ID: 24192537
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
[TBL] [Abstract][Full Text] [Related]
15. IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells.
Parrot T; Allard M; Oger R; Benlalam H; Raingeard de la Blétière D; Coutolleau A; Preisser L; Desfrançois J; Khammari A; Dréno B; Labarrière N; Delneste Y; Guardiola P; Gervois N
Eur J Immunol; 2016 Jul; 46(7):1770-82. PubMed ID: 27094152
[TBL] [Abstract][Full Text] [Related]
16. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
17. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression.
Su Y; Huang X; Raskovalova T; Zacharia L; Lokshin A; Jackson E; Gorelik E
Cancer Immunol Immunother; 2008 Nov; 57(11):1611-23. PubMed ID: 18327580
[TBL] [Abstract][Full Text] [Related]
19. T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
Di Gennaro P; Gerlini G; Caporale R; Sestini S; Brandani P; Urso C; Pimpinelli N; Borgognoni L
Cancer Lett; 2018 Mar; 417():124-130. PubMed ID: 29306022
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E
Li H; Chen HY; Liu WX; Jia XX; Zhang JG; Ma CL; Zhang XJ; Yu F; Cong B
Immunol Lett; 2017 Nov; 191():63-72. PubMed ID: 28963072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
